Albumin: Clinical Trials

76 trials of Albumin, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

43 completed, 11 unknown, 7 recruiting, 7 withdrawn. 27 Not applicable, 17 Phase 4, 16 Phase 2, 9 Phase 3, 3 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable27Completed 17, Unknown 7, Recruiting 2, Not yet recruiting 1
Phase 417Completed 11, Withdrawn 2, Not yet recruiting 1, Recruiting 1, Terminated 1, Unknown 1
Phase 216Completed 5, Withdrawn 5, Recruiting 2, Terminated 2, Unknown 2
Phase 39Completed 4, Terminated 2, Not yet recruiting 1, Recruiting 1, Unknown 1
Phase 13Completed 2, Terminated 1

Follow Albumin: new trials by email Literature Review of Albumin trials Research Report on Albumin

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Albumin in Acute Variceal Bleeding
Albumin - Acute Variceal Bleeding, Cirrhosis
Phase 3Not yet recruitingKing George's Medical University602026-03-012026-02-09
Modulation of Cerebral Ischemia by Albumin
Albumin infusion, Placebo Injection - Ischemic Stroke
Phase 2RecruitingUniversity Hospital Hradec Kralove1002026-02-032026-05-06
Albumin for Patients With Acute Large Vessel Occlusive Stroke Undergoing Endovascular Therapy -2
Albumin, Endovascular treatment - Acute Ischemic Stroke
Phase 3RecruitingCapital Medical University11922025-12-182026-10-29
The Intensive Care Platform Trial
Albumin, No albumin use, LMWH in weight-adjusted dose - Intensive Care Patients, Intensive Care Unit Patients
Phase 4RecruitingAnders Perner100002025-06-262026-10-05
Effect of Single vs Repeated Cycles of a Combination of Granulocyte Colony Stimulating Factor and Darbepoetin vs Standard Medical Treatment on Immunometabolic Profile in Patient With Early Decompensated Cirrhosis.
Darbepoetin, G-CSF, Lactulose - Decompensated Liver Cirrhosis
Not applicableRecruitingInstitute of Liver and Biliary Sciences, India602025-06-042026-05-22
Comparison of Safety and Efficacy of Tailored Versus Fixed Dose Albumin for the Management of Patients With Cirrhosis and Sepsis Associated Acute Kidney Injury
Albumin, Standard Medical Treatment - Liver Cirrhosis, Acute Kidney Injury
Not applicableNot yet recruitingInstitute of Liver and Biliary Sciences, India1002025-01-312025-02-05
Transthoracic Echocardiographic Monitoring of Cardiac Output Effects of Colloid Preload and Crystalloid Coload During Cesarean Delivery Under Spinal Anesthesia
Transthoracic Echocardiography, Ringer lactate 1000 ml, Albumin - Pregnancy, Cesarean Delivery
Not applicableCompletedSameh Fathy1622024-10-272025-05-21
Evaluation of Low-dose Albumin and Midodrine Versus Midodrine Alone in Outcome of Recurrent Ascites in Patients With Decompensated Cirrhosis.
Albumin, Midodrine, Standard of Care - Decompensated Cirrhosis
Not applicableUnknownInstitute of Liver and Biliary Sciences, India1002024-02-102024-02-07
Study on the Role of Human Serum Albumin in Large Acute Ischemic Stroke of Anterior Circulation After Thrombectomy
Patients with AIS receive intravascular therapy, and within 10 minutes after the surgery, they are administered 100ml of 20% human albumin intravenously (infused within 30 minutes). - Cerebral Ischemia
Not applicableRecruitingTingyu-Yi1002024-01-302024-10-08
Midodrine Plus Albumin Versus Midodrine Alone to Prevent Cirrhosis Related Complications in Children With Cirrhosis and Ascites
Midodrine, albumin, Standard Medical Treatment - Liver Cirrhosis
Not applicableCompletedInstitute of Liver and Biliary Sciences, India612023-12-222026-03-10
Intra-arterial Albumin Infusion After Endovascular Therapy for Stroke Patients
Albumin - Stroke, Acute Ischemic, Albumin
Phase 1CompletedTianjin Huanhu Hospital572023-08-012025-07-22
Coagulation Parameters With Albumin in Decompensated Cirrhosis (CoPA-D).
Albumin, Standard of Care - Decompensated Cirrhosis
Not applicableCompletedInstitute of Liver and Biliary Sciences, India1202023-07-302025-06-04
Effect of Balanced Saline Solution and Albumin on Volume Expansion in Shock Patients
Compound sodium acetate ringer injection, Albumin - Shock
Phase 4Not yet recruitingPeking Union Medical College Hospital5002022-08-012022-07-19
Monotherapy IVIG Gamunex-C for HMG-CoA Reductase Auto-Antibody Positive Necrotizing Myopathy Treatment (The MIGHT Trial)
Gamunex-C, Albumin - Immune-Mediated Necrotizing Myopathy
Phase 2WithdrawnUniversity of Washington2022-05-012022-10-24
Randomized Trial of Fresh Frozen Plasma Versus Albumin in Acute Burn Resuscitation
Fresh Frozen Plasma - Burns
Not applicableCompletedUniversity of Colorado, Denver592022-02-172025-11-13
Immune Checkpoint Inhibitors Nephrotoxicity
Early kidney damage biomarkers, Predisposition to kidney injury biomarkers - Kidney Injury, Antineoplastics Toxicity
RecruitingR. Laura Vicente Vicente2202021-05-192025-02-26
Evaluation of Albumin and Midodrine Versus Albumin Alone in Outcome of Refractory Ascites in Patients With Decompensated Cirrhosis.
Midodrine, Albumin, Standard Medical Treatment - Liver Cirrhosis
Not applicableUnknownInstitute of Liver and Biliary Sciences, India2002021-05-152021-06-15
The Acute Burn ResUscitation Multicenter Prospective Trial
Albumin Human - Burn Injury
Not applicableCompletedAmerican Burn Association1012021-04-222026-05-20
Efficacy of Targeted And Response-Guided Albumin Therapy Versus Standard Medical Treatment In Outcomes Of Recurrent Ascites In Patients With Decompensated Cirrhosis.
Albumin, Standard Medical Treatment - Decompensated Cirrhosis
Not applicableUnknownInstitute of Liver and Biliary Sciences, India1002020-12-302020-12-22
Midodrine and Albumin in Patients With Refractory Ascites
Albumin, Midodrine, Standard medical therapy (SMT) - Refractory Ascites
Phase 3UnknownPost Graduate Institute of Medical Education and Research, Chandigarh1142020-11-012020-11-09

Showing 20 of 76. Sign in to see all of them.

Conditions studied

Fibrosis (10)  ·  Liver Cirrhosis (7)  ·  Acute-On-Chronic Liver Failure (4)  ·  Ascites (4)  ·  Ischemic Stroke (4)  ·  Renal Insufficiency (4)  ·  Shock, Septic (4)  ·  Acute Kidney Injury (3)  ·  Burns (3)  ·  Disease (3)  ·  Hepatic Encephalopathy (3)  ·  Sepsis (3)  ·  Edema (2)  ·  Hepatorenal Syndrome (2)  ·  Hyponatremia (2)

Sponsors

Institute of Liver and Biliary Sciences, India (16)  ·  Baylor College of Medicine (2)  ·  Hospices Civils de Lyon (2)  ·  Instituto Grifols, S.A. (2)  ·  Montefiore Medical Center (2)  ·  R. Laura Vicente Vicente (2)  ·  All India Institute of Medical Sciences (1)  ·  American Burn Association (1)  ·  Anders Perner (1)  ·  Anna Cruceta (1)  ·  Asan Medical Center (1)  ·  Baxalta now part of Shire (1)  ·  CSL Behring (1)  ·  Cairo University (1)  ·  Capital Medical University (1)

Countries

India (17)  ·  United States (16)  ·  Spain (10)  ·  France (5)  ·  China (4)  ·  Austria (3)  ·  Canada (3)  ·  Finland (3)  ·  Italy (3)  ·  Brazil (2)  ·  Denmark (2)  ·  Egypt (2)  ·  Germany (2)  ·  Netherlands (2)  ·  United Kingdom (2)

Top investigators

Samuel Sigal, MD (2)  ·  Adil E Bharucha, MBBS, MD (1)  ·  Agustin Albillos (1)  ·  Ahmed Kareem (1)  ·  Aide McCormick (1)  ·  Alexander Gerbes (1)  ·  Alexandre Araujo (1)  ·  Anders Granholm, MD (1)  ·  Anders Perner, Professor (1)  ·  Andrea de Gottardi (1)  ·  Arno P Nierich, MD, PhD. (1)

Results publications

PMID 30905652, PMID 10347109, PMID 11772973, PMID 15740535, PMID 16460491, PMID 16552809, PMID 16966752, PMID 18251131, PMID 18410283, PMID 18492024, PMID 18547224, PMID 20924555, PMID 21484145, PMID 21546491, PMID 22095893, PMID 22732511, PMID 22801062, PMID 23872605, PMID 23934414, PMID 23984731, PMID 24067785, PMID 24076337, PMID 24635772, PMID 25099709, PMID 25623044, PMID 25954497, PMID 26325387, PMID 26831575, PMID 27462118, PMID 28241354, PMID 28245467, PMID 28270187, PMID 28510741, PMID 29768150, PMID 30138685, PMID 31394283, PMID 31802120, PMID 31849085, PMID 32111230, PMID 32576140, PMID 33407747, PMID 34740932, PMID 34768464, PMID 34791571, PMID 35120736, PMID 35852528, PMID 35887529, PMID 36810101, PMID 37568887, PMID 37932787

NIH funding

2019 (2), 2008 (1), 2023 (1), P01DK068055 (1), U01NS054630 (1), UL1TR000135 (1)